Senseonics Holdings (SENS) Enterprise Value (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Senseonics Holdings | 316.18 Mn | 251.85 Mn | 6.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -58.63% |
| Dec 31, 2025 | 78.37% |
| Sep 30, 2025 | -48.32% |
| Jun 30, 2025 | -96.79% |
| Mar 31, 2025 | 14.25% |
| Dec 31, 2024 | -0.13% |
| Sep 30, 2024 | -112.72% |
| Jun 30, 2024 | 64.48% |
| Mar 31, 2024 | 9.54% |
| Dec 31, 2023 | 43.88% |
| Sep 30, 2023 | -65.83% |
| Jun 30, 2023 | 46.53% |
| Mar 31, 2023 | -101.14% |
| Dec 31, 2022 | 61.18% |
| Sep 30, 2022 | -15.34% |
| Jun 30, 2022 | 9.42% |
| Mar 31, 2022 | -167.76% |
| Dec 31, 2021 | -1.77% |
| Sep 30, 2021 | 67.91% |
| Jun 30, 2021 | -3,482.40% |
| Mar 31, 2021 | 52.71% |
| Dec 31, 2020 | 31.03% |
| Sep 30, 2020 | -22.22% |
| Jun 30, 2020 | -72.64% |
| Mar 31, 2020 | 87.76% |
| Dec 31, 2019 | 21.74% |
| Sep 30, 2019 | -99.98% |
| Jun 30, 2019 | 37.02% |
| Mar 31, 2019 | 24.21% |
| Dec 31, 2018 | 16.09% |
| Sep 30, 2018 | 15.04% |
| Jun 30, 2018 | -194.97% |
| Mar 31, 2018 | -78.47% |
| Dec 31, 2017 | 30.83% |
| Sep 30, 2017 | -27.20% |
| Jun 30, 2017 | -200.85% |
| Mar 31, 2017 | 32.29% |
| Dec 31, 2016 | 20.78% |
| Sep 30, 2016 | 29.06% |
| Jun 30, 2016 | 3.14% |
| Mar 31, 2016 | -848.51% |
| Dec 31, 2015 | 67.80% |
| Sep 30, 2015 | -46.83% |
| Jun 30, 2015 | 40.07% |
| Mar 31, 2015 | 26.52% |
| Dec 31, 2014 | -428,119.05% |
| Sep 30, 2014 | 55.81% |